Results 271 to 280 of about 311,423 (321)

Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy. [PDF]

Vaccines (Basel)
Mokalla VR, Gundarapu S, Kaushik RS, Rajput M, Tummala H.   +4 more
europepmc   +1 more source

Development of Nanobody-Expressing Nanosomes for Neutralization of Influenza Virus. [PDF]

J Microbiol Biotechnol
Kim T, Jang IH, Shin S, Kang J, Ahn HJ, Moon S, Kim J, Ryu JH, Lee KA.   +8 more
europepmc   +1 more source

N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineages. [PDF]

J Virol
Page CK, Mubassir MHM, Chopra P, Gay LC, Geiger G, Ray SD, Shepard JD, Miller RJ, Perez D, Bahl J, Boons GJ, Tompkins SM.   +11 more
europepmc   +1 more source

Long-Term Immunogenicity and Protection of a rHVT-H9/Y280 Vaccine Against H9N2 Avian Influenza Virus in Commercial Layers with High Maternal Antibodies. [PDF]

Animals (Basel)
Kim SW, Park JY, Son JE, Zheng KQ, Yu CD, Kim KW, Jeon WB, Choi YR, Jang HK, Wei B, Kang M.   +10 more
europepmc   +1 more source